APA (7th ed.) Citation

C, S., J, K., TL, F., DH, G., P, B., K, S., . . . S, G. (2020). Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza. PLoS pathogens, 16(8), e1008716. https://doi.org/10.1371/journal.ppat.1008716

Chicago Style (17th ed.) Citation

C, Scott, et al. "Site-directed M2 Proton Channel Inhibitors Enable Synergistic Combination Therapy for Rimantadine-resistant Pandemic Influenza." PLoS Pathogens 16, no. 8 (2020): e1008716. https://doi.org/10.1371/journal.ppat.1008716.

MLA (9th ed.) Citation

C, Scott, et al. "Site-directed M2 Proton Channel Inhibitors Enable Synergistic Combination Therapy for Rimantadine-resistant Pandemic Influenza." PLoS Pathogens, vol. 16, no. 8, 2020, p. e1008716, https://doi.org/10.1371/journal.ppat.1008716.